Catalyst Wire Dossier Catalyst Wire Dossier

Sesame protein oral immunotherapy

sesame protein oral immunotherapy
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sesame protein oral immunotherapy, covering 2025-08-06 to 2025-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Sustained Unresponsiveness (SU) to Sesame Protein Following Low-dose Oral Allergen-specific Immunotherapy [NA]

See pricing